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ABSTRACT 
OBJECTIVE: The goal of this study was to establish normative values under ambient light 
conditions for measurements of quantitative pupillometry in children.  
METHODS: This was a cross-sectional analysis of pupillometry values obtained in children. 
Quantitative pupillomentry measurements were obtained from children between 1 and 18 years of age 
being seen for either a well child check or other outpatient appointment. Participants were excluded if 
they were in pain, on any medication known to affect pupil size (i.e. opioids, stimulants), or had any 
chronic neurologic conditions.  
RESULTS: A total of 242 children were enrolled in this study, with pupillometry readings 
obtained from a total of 171 children after exclusions. Maximum and minimum pupil size increased 
slightly with age; however, the correlation was weak (r = 0.14 and r = 0.16). Similarly weak correlations 
with age also were observed for maximum constriction velocity (r = -0.12) and dilation velocity (r = 
0.05). No differences were observed between males and females for any of the pupil parameters. 
Maximum (5.35 mm vs. 4.91 mm) and minimum (3.71 mm vs. 3.36 mm) pupil sizes were significantly 
larger in Whites than African-American participants.  
CONCLUSIONS: Pupil size and reactivity show little correlation with age, appear to be relatively 
independent of ontogeny, and therefore would not be expected to significantly impact further exploration 
in utilizing pupillometry as a biomarker across the pediatric age range. Differences in race should be 
taken into consideration when pupillometry is used in mixed populations.  
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Introduction 
 Pupillometry is defined as “the measurement of variations in the diameter and the pupillary 
aperture of the eye,” and includes the following parameters: maximum (resting) and minimum (following 
light stimulus) pupil diameter, average and maximum constriction velocity, and dilation velocity 
(following light stimulus).[1] The clinical usage of pupillometry has gained renewed interest as a clinical 
biomarker, largely due to the introduction of user-friendly, reliable, and portable measurement devices.[2] 
This development of infrared pupillometers has removed much of the subjectivity involved in quantifying 
pupil dynamics, making readings of pupil size and reactivity simple, efficient, and extremely accurate. 
These advances have allowed for novel applications of pupillometry by clinicians in pharmacology and 
critical care research. 
In response to these advancements, pupillometry has been applied in several experimental 
settings,  including monitoring for early changes in intracranial pressure (via the pupillomotor nuclei in 
the dorsal midbrain and the oculomotor nerve),[4] associating oxycodone and fentanyl plasma 
concentrations with pupil size (opioids constrict the pupil via cortical inhibition of the Edinger-Westphal 
nucleus),[5-7] and correlating subjective pain scores with a standardized pupillary dilatation reflex (in 
response to a noxious stimuli) in post-operative patients from alterations in sympathetic and 
parasympathetic tone.[8] Additionally, pupillometry has been shown to correlate with the efficacy of 
tramadol in healthy volunteers, serving as a surrogate for CYP2D6 activity and potentially identifying 
individuals who may not have the intended therapeutic effect with standard dosing of the drug,[9] with 
similar findings shown with alfentanil and CYP3A4 activity.[10]  
In order to accurately assess pupil size and reactivity values obtained in children, it is necessary 
to consider how pupil parameters obtained under experimental conditions compare to pupil parameters in 
healthy children. Several prior studies have evaluated normal pupil size and reactivity in children in a 
variety of ways.[11-14]
 
MachLachlan and Howland describe normal values under low light conditions for 
pupil diameters in children down to one month of age; however, subjects were limited to only pupil 
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diameter due to the photographic technology utilized.[11] Taylor et al. reported pupil size and reactivity 
values under ambient light conditions in healthy volunteers from 1-87 years of age, but reported group 
means rather than examining changes with age.[12] Kohnen et al. reported low light pupil size and 
reactivity utilizing a Colvard infrared pupillometer but were limited in total sample size (n=83) and 
measurements in older children.[13] Finally, Boev et al. describe normative pupillometry data in healthy 
pediatric volunteers (n=90) from 1-18 years of age under ambient light conditions utilizing an older 
Neuroptics pupillometer (Forsite); however, they reported their data in age groups (0-2, 2-6, 6-12, 12-18 
years), making it difficult to assess changes with age in a detailed manner.[14]  
The purpose of this study was to further characterize normal pupil size and reactivity under 
ambient light conditions, assess the feasibility of using pupillometers in children down to 12 months of 
age (i.e. how realistic it is to obtain readings from a pupillometer across an age spectrum), and determine 
differences (if any) in age, sex, and race.  
 
Methods 
Study design 
This was a cross-sectional study of healthy male and female children between the ages of 1 and 
18 years using convenience sampling at three area pediatric clinics. This study was approved by the 
Institutional Review Board with oversight for all locations. Participants were enrolled with informed 
permission/assent.  
 
Sample population  
Participants were recruited during well child checks (regularly scheduled outpatient visits for 
assessment of growth and development) or during other outpatient clinic appointments. Participants were 
excluded if they had any neurologic illness that may affect pupil size, were presently in pain defined as a 
pain score greater than one (as expressed by either the participant or parent/guardian), were taking any 
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medication known to affect pupil size (opioids, stimulants, or anticholinergics), or were unwilling/unable 
to participate.  
 
Outcome measures 
Pupil size and reactivity data was obtained using a Neuroptics PLR-200 pupillometer (Neuroptics, Inc, 
Irvine, California) under ambient light conditions. This device is a handheld, digital infrared, monocular 
pupillometer that auto-focuses, auto-calibrates, and controls for vertex distance. It measures the best 
circular fit of the pupil, records 30 measurements per second, and reports mean values while excluding 
outliers. As shown in a recent study, the Neuroptics pupillometer has a high interobserver agreement and 
repeatability.[3] For the reading, a rubber cup on the pupillometer is placed around the child’s eye to 
block out peripheral light.  Once the pupil is detected, the pupillometer determines the resting (maximum) 
pupil diameter (mm), flashes a brief standardized light stimulus, and then determines the resulting average 
and maximum pupil constriction velocity (mm/s), minimum pupil diameter (mm), time to minimum 
diameter (s), percent constriction (resting minus minimum diameter), and dilation velocity (mm/s) (Figure 
1, used with permission).   
Figure 1. Neuroptics PLR-200 Pupillometer output 
A and B = maximum and average constriction velocity; C = dilation velocity; D = maximum pupil size; E 
= minimum pupil size; F = percent constriction  
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The validity of each reading is displayed in the output and determined by the software integrated 
within the device. A maximum of three attempts were made in each individual. If more than one reading 
was obtained, the average of those readings is reported. If no valid readings were obtained after three 
attempts, no additional readings were attempted. 
 
Covariates 
Parents or guardians completed a self-report questionnaire in order to ascertain the participant’s 
age, race, ethnicity, current state of pain (based on a scale from 1-10), any known illness, and current 
medications. 
 
Analysis plan 
The data were analyzed by descriptive statistical methods. Maximum and minimum pupil sizes 
are presented as means with standard deviation categorized as yearly age groups. One way ANOVA tests 
were used to compare pupil parameters of all races, while independent t-tests were used for direct 
comparisons when comparing pupil parameters between sex and race (White vs. African-American, 
White vs. Other, and African-American vs. Other). Chi-square tests were used to compare differences 
between valid and invalid readings. Pearson’s correlation test (r) was utilized in order to assess the linear 
relationship between age and pupil parameters.   
 
Results 
A total of 242 participants were approached for study participation.  Of these, 7 participants were 
ineligible due to being on a medication known to affect pupil size and reactivity, while 7 reported pain 
scores of greater than 1 (based on a scale of 1-10).  Fifty-seven participants were excluded due to invalid 
readings as determined by the software. No participants were excluded due to neurologic illness. Nearly 
half (47%) of the readings deemed as invalid by the software occurred  in children under 5 years of age (p 
5 
 
< 0.01), while gender and race in participants with excluded readings was nearly identical to the overall 
population (p > 0.05) (Table 1).   
Table 1. Demographics of valid vs. invalid readings 
Demographics Valid Invalid Percent Invalid P-value 
Age <5y 34 27 44 0.0001 
Age >5y 137 30 18  
Gender*       
   Male 85 27 24 0.9681 
   Female 86 29 25  
Race       
   White 100 38 28 0.5406 
   Black 47 13 22  
   Other 24 6 20  
 
  
Data from 171 participants (50% male) were analyzed, with a self-identified race distribution of 
the enrolled sample of 59% White, 28% African-American, and 13% other. Of the total population, 19% 
self-identified as Hispanic.  
Average maximum and minimum pupil sizes by age are displayed in Table 2. Overall, both 
maximum and minimum pupil size were shown to increase slightly for the entire population until around 
11 years of age and subsequently plateau; however, this finding was not found to be statistically 
significant for maximum pupil size and the linear correlation between age and maximum/minimum pupil 
size was very weak   (r = 0.14, slope (b) = 0.81, 95% confidence intervals (CI) = -0.04-1.66; p = 0.06, and 
r = 0.16, b = 1.20, 95% CI = 0.08-2.31; p = 0.04). Weak and non-significant correlations with age were 
also observed for maximum constriction velocity (r = -0.12, b = -0.67, 95% CI = -1.49-0.15; p = 0.11) 
and average dilation velocity (usable n = 140) (r = 0.05, b = 0.90, 95% CI = -1.89-3.68; p = 0.53) (Figure 
2). Average constriction velocity also showed a weak correlation with age (r = -0.22, b = -1.60, 95% CI =      
-2.67- (-)0.53; p < 0.01), as did percent constriction (r = 0.10, b = 0.09, 95% CI = -0.05-0.23; p = 0.21). 
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Figure 2. Scatter plot of maximum constriction velocity and dilation velocity 
 
 
Table 2. Average values of maximum and minimum pupil sizes 
 
Age 
(years) 
Number of 
participants 
Maximum Pupil 
Size (mm (SD)) 
Minimum Pupil 
Size (mm (SD)) 
1-2 8 4.82 (1.13) 3.44 (0.71) 
2-3 7 4.64 (0.84) 3.10 (0.64) 
3-4 6 5.02 (0.83) 3.28 (0.73) 
4-5 13 5.27 (0.60) 3.50 (1.09) 
5-6 16 4.90 (0.60) 3.34 (0.53) 
6-7 14 5.11 (0.73) 3.52 (0.61) 
7-8 11 5.31 (0.87) 3.73 (0.65) 
8-9 8 4.99 (1.02) 3.42 (0.66) 
9-10 12 5.16 (0.92) 3.62 (0.74) 
10-11 17 5.55 (0.46) 3.83 (0.42) 
11-12 10 5.66 (0.30) 3.70 (0.37) 
12-13 16 5.19 (0.72) 3.59 (0.49) 
13-14 9 5.59 (0.63) 3.90 (0.55) 
14-15 7 5.41 (1.04) 3.90 (0.65) 
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15-16 7 5.34 (0.41) 3.67 (0.50) 
16-17 5 5.07 (0.48) 3.61 (0.51) 
17-18 5 4.37 (1.12) 3.18 (0.65) 
Total /  
Average 
171 5.19 (0.77) 3.57 (0.64) 
 
No differences were observed between males and females for any of the pupil parameters. One 
way ANOVA tests comparing race and each pupil parameter revealed significant differences for 
maximum (p = 0.02) and minimum (p < 0.01) pupil size. Mean maximum pupil size was significantly 
larger in Whites than African-American participants (5.35 mm vs. 4.91 mm) (p < 0.01), as was minimum 
pupil size (3.71 mm vs. 3.36 mm) (p < 0.01) (Table 3).  
Table 3. Mean comparisons of gender and race 
Mean Pupil Parameter Male  Female White Black 
Maximum Pupil Size (mm) 5.18 (0.78) 5.19 (0.76) *5.35 (0.69) *4.91 (0.87) 
Minimum Pupil Size (mm) 3.58 (0.55) 3.59 (0.62) *3.71 (0.55) *3.36 (0.58) 
Percent Change (%) -30.49 (4.98) -30.55 (4.78) -30.34 (5.04) -30.98 (4.77) 
Average Constriction Velocity 
(mm/s) 
-3.38 (0.63) -3.44 (0.57) -3.46 (0.61) -3.35 (0.60) 
Maximum Constriction Velocity 
(mm/s) 
-4.45 (0.87) -4.53 (0.74) -4.55 (0.79) -4.39 (0.87) 
Dilation Velocity (mm/s) 1.01 (0.22) 1.02 (0.29) 1.01 (0.24) 1.07 (0.24) 
*p-value < 0.05 
     
When stratified by race, correlations were statistically significant for maximum pupil size and age 
in Whites (r = 0.26, b = 1.60, 95% CI = 0.40-2.80; p = 0.01) but not African-Americans (r = 0.10, b = 
0.53, 95% CI = -1.11-5.16; p = 0.52) (Figure 3). Similarly, minimum pupil size and age was statistically 
significantly (though weakly correlated) in Whites (r = 0.26, b = 2.02, 95% CI = 0.53-3.51; p = 0.01) but 
not African-Americans (r = 0.13, b = 1.09, 95% CI = -1.34-3.51; p = 0.37) (Figure 4). No differences in 
any of the pupil parameters were observed when comparing the other racial groups.  
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Figure 3. Maximum pupil sizes for Whites and African-Americans.  
 
Figure 4. Minimum pupil sizes for Whites and African-Americans.  
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Discussion 
Advances in the technology of pupillometers have led to an increased utilization of pupillometry 
as an assessment tool in several areas. Establishing normative values in pediatrics is imperative to 
accurately assist in the interpretation of pupil response in pediatric studies that employ pupillometry as a 
tool. This study is the first to provide quantitative data of pupil size and reactivity under ambient light 
conditions across a representative sample of healthy children of all ages. These results add to the existing 
body of literature on normal ranges of pupil size and reactivity throughout child development, showing a 
slight increase in maximum and minimum pupil size with age. Dilation velocity showed little change over 
the pediatric age range, while maximum constriction velocity portrayed a slight decrease.  Additionally, 
significant differences were found in two parameters (maximum/minimum pupil) when comparing White 
and African-American children (Table 3), suggesting that race should be considering when interpreting 
pupillometry data. Interestingly, Whites also had higher correlations between maximum/minimum pupil 
size and age as compared to African-Americans, although their magnitude was weak.  
It also is important to note that no differences between males and females were found in pupil 
parameters, consistent with a prior report in adult participants 18-80 years of age using the same brand of 
pupillometer indicating that no gender differences were found in pupils adjusted to dim light settings.[15]  
Several variables were compared in order to identify subpopulations in whom this device may be more or 
less feasible. Of the three demographics (age, gender, and race) compared between valid and invalid 
readings, gender and race showed comparable proportions between the two groups. In contrast, a 
significantly higher proportion of invalid readings occurred in children less than 5 years of age, 
suggesting that the feasibility of obtaining valid readings is impacted by age, and that younger age is an 
important consideration when anticipating obtaining pupillometry readings. Additionally, although data 
regarding iris color was not included in this study, a recent study showed no variation between individuals 
with different iris colors.[15]   
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While newer pupillometers do allow for simple attainment of measurements, the reliability of the 
device is an important consideration and has been addressed by several studies. Meeker et al. compared 
measurements taken manually by several different clinicians (neurosurgeons, neurosurgical interns, and 
advanced practice nurses) to those obtained with an automated, portable pupillometer.  They 
demonstrated that pupil measurements obtained via an infrared pupillometer have much lower inter-
examiner disagreement and were also able to detect pupillary changes earlier than with manual 
examination.[16] When comparing three different brands of pupillometers, the Neuroptics pupillometer 
demonstrated better reliability and agreement between users as compared to the other two.[3] An 
additional study comparing the Neuroptics PLR-200 with the laboratory standard of infrared photography 
showed clinically satisfactory accuracy, with none of the readings showing a difference greater than +/- 
0.5 mm. [17]  
As several neuroanatomical pathways contribute to pupil size and reactivity, numerous clinical 
applications may be possible. Pupillary response to pain and analgesia has been proposed as an objective 
tool for pain assessment and has been shown to be a more sensitive marker of pain and analgesic drug 
response in children and adults when compared to traditional hemodynamic markers.[18,19] Capturing 
the extent of pupil dilation can provide an index of acute nociceptive input via autonomic innervation of 
the iris muscles, [20] while capturing the extent of reduction in this pupillary response during exposure to 
opioid pain medicine can provide an index of a given drug’s pharmacological effect by reflecting the 
extent of occupancy of mu and kappa opioid receptors in the central nervous system.[18] Furthermore, 
pain assessment in children or non-verbal patients is often difficult to accurately assess, and pupillometers 
may offer a new tool for advancing the understanding of individual differences in pain and analgesic 
response in children by providing an objective measurement of pain and analgesia.  
While approximate values for age ranges can be estimated from the data, we found a considerable 
amount of inter-individual variability for maximum and minimum pupil sizes. As a result, it may be likely 
that the most relevant information is gained by examining changes in an individual’s own dynamic values 
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(i.e., constriction/dilation velocity, percent constriction) or change in pupil size from their baseline values. 
Furthermore, this study shows that pupil readings are possible in younger children down to 12 months of 
age, although as previously stated valid measurements were more difficult to obtain for children less than 
5 years of age. In order to increase the likelihood of obtaining a reading from a child less than 5 years, 
parents assisted in helping to steady the child’s head long enough to obtain a reading. Although an 
advantage of the pupillometer is its ease of use, patient-operator interaction and operator proficiency is 
still required when obtaining readings. The development of a pupillometer requiring less active 
participation for obtaining readings in younger children (e.g., obtaining readings from a distance, software 
that integrates motion better, etc.) may be useful to capture data in younger children.  
This study adds important information to the existing knowledge related to normal pupil size and 
reactivity in healthy children. Due to methodological differences, previous studies in this area have 
produced varying results. MachLachlan et al. used a large sample size of participants 1-19 years of age to 
quantify typical pupil parameters; however, their results were limited to only resting pupil diameter and 
interpupillary distance under low light conditions.[11]  Similarly, Kohnen et al. reported only mean pupil 
size values under scotopic conditions in children between 0-15 years of age; of note, these researchers 
similarly found an increase in pupil size until approximately 11 years of age.[13] Taylor et al. reported 
size and reactivity data in healthy volunteers between 1-87 years of age but collapsed data across the 
entire age range.[12]  Lastly, Boev et al. reported normative quantitative pupillometry data in 90 children 
1-18 years of age.[14]  Results from the Boev et al. study contrasted with our findings in that mean values 
for maximum and minimum pupil size from our study were consistently larger. 
The study was limited by the exclusion of children less than one year of age as well as the 
convenience sampling utilized for enrollment, which may introduce an element of systematic bias.  Given 
that a significant amount of neurodevelopment occurs prior to one year of age, it is possible that pupil size 
and/or reactivity may appreciably change throughout this timeframe.  Our participant population had a 
disproportionate number of White participants as compared to African-Americans. Additionally, because 
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ambient light was not explicitly defined in this study some of the variability may be due to differences in 
ambient lighting between the different enrollment locations.  
It is important that future studies in pupillometry take into consideration as many factors as 
possible that could affect pupil size, including patient population demographics as well as lighting in the 
environment readings are taken. Future studies to assess quantitative puillometry in children less than one 
year of age will likely require technological advancements in the way these readings are obtained. 
Furthermore, studies examining pupil size and reactivity in neurological disorders and medications that 
affect pupil dynamics are also needed.  
In conclusion, pupil size and reactivity as quantified by infrared pupillometry appear to be 
relatively independent of ontogeny in children greater than one year of age, and therefore age would not 
be expected to significantly impact future studies utilizing pupillometry as a biomarker across the 
pediatric age range. Due to the absence of significant changes with age, extrapolation of adult 
pupillometry data to the pediatric population may be reasonable. Additionally, future studies utilizing 
pupillometry in mixed racial populations must take into account that differences may exist. These data 
provide an important baseline and are critical considerations for interpretation of future pediatric studies 
using pupillometry as a pharmacodynamic biomarker.  
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